This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.
Additional locations may be listed on ClinicalTrials.gov for NCT06811038.
Locations matching your search criteria
United States
Washington
Seattle
Fred Hutch/University of Washington/Seattle Children's Cancer ConsortiumStatus: Approved
Contact: Jonathan B. Bricker
Phone: 206-667-5074
PRIMARY OBJECTIVE:
I. To determine whether providing Hispanic adults with free nicotine replacement therapy (NRT) in combination with iCanQuit yields higher point prevalence abstinence (PPA) than iCanQuit alone.
SECONDARY OBJECTIVE:
I. To determine the cost-effectiveness of iCanQuit plus NRT versus (vs.) iCanQuit alone.
EXPLORATORY OBJECTIVE:
I. To evaluate each intervention’s reach, effectiveness, adoption, implementation, and maintenance for Hispanic adults using the reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) framework, and conduct interviews with participants and stakeholders in tobacco control to identify barriers and facilitators to dissemination to Hispanic adults.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants receive access to the iCanQuit smartphone application for 12 months and complete personalized quit plans with education regarding managing urges, motivation, and relapse prevention, on-demand help with tracking of daily cigarette consumption, and monitoring of urges passed without smoking.
ARM II: Participants receive access to the iCanQuit smartphone application for 12 months and complete personalized quit plans with education regarding managing urges, motivation, and relapse prevention, on-demand help with tracking of daily cigarette consumption, and monitoring of urges passed without smoking. Participants also receive NRT patch(es) and gum or lozenges to use per the usage instructions tailored to the participants’ baseline smoking levels. In addition, participants receive daily push notifications with NRT dosage and refill reminders for 12 months.
After completion of study intervention, patients may be followed up at 12 months.
Lead OrganizationFred Hutch/University of Washington/Seattle Children's Cancer Consortium
Principal InvestigatorJonathan B. Bricker
